Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemia. Sui P, Li Y, Hong J, Delma CR, et al. Leukemia 2025 Nov 17. doi: 10.1038/s41375-025-02803.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sui P, Li Y, Hong J, Delma CR, et al. Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemia. Leukemia 2025 Nov 17. doi: 10.1038/s41375-025-02803.
PMID: 41249566